QQ客服 官方微博 反馈留言

	XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer
	Zhu, Xiaoli/55696701800[0]; Sun, Xinchen/35277753900[1]; Chen, Baoan/7408611401[2]; Sun, Ning/35367161400[3]; Cheng, Hongyan/55790528800[4]; Li, Fan/56711385100[5]; Zhang, Hongming/35729799200[6]; Feng, Jifeng/9744825000[7]; Qin, Shukui/55984746100[8]; Cheng, Lu/37053512300[9]
刊名	Chinese Medical Journal
	2010
卷号	123期号:23
关键词	Chemotherapy Gene-chip/microarray Non-small-cell lung cancer Single nucleotide polymorphism Xeroderma pigmentosum group C
ISSN号	0366-6999
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4934767
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhu, Xiaoli/55696701800[0],Sun, Xinchen/35277753900[1],Chen, Baoan/7408611401[2],et al. XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer[J]. Chinese Medical Journal,2010,123(23).
APA	Zhu, Xiaoli/55696701800[0].,Sun, Xinchen/35277753900[1].,Chen, Baoan/7408611401[2].,Sun, Ning/35367161400[3].,Cheng, Hongyan/55790528800[4].,...&Lu, Zuhong/55637289700[10].(2010).XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer.Chinese Medical Journal,123(23).
MLA	Zhu, Xiaoli/55696701800[0],et al."XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer".Chinese Medical Journal 123.23(2010).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。